# BIOME-Bench

**A Benchmark for Biomolecular Interaction Inference and Multi-Omics Pathway Mechanism Elucidation**

<div align="center">
  <img src="imgs/logo.png" width="48% biological-atom" /> <br/>
    <span>*Logoç”±Nano Bananaç”Ÿæˆ</span>
</div>
<p align="center">
    <b>ğŸŒ Language:</b> ä¸­æ–‡ | <a href="README.md">English</a>
</p>



## ğŸŒŸ ç®€ä»‹

**BIOME-Bench** æ˜¯ä¸€ä¸ªåŸºäºç§‘å­¦æ–‡çŒ®çš„è¯„ä¼°æ¡†æ¶ï¼Œæ—¨åœ¨è¯„ä¼°å¤§è¯­è¨€æ¨¡å‹åœ¨**ç”Ÿç‰©åˆ†å­äº’ä½œæ¨ç†**ï¼ˆBiomolecular Interaction Inference, BIIï¼‰å’Œ**ç«¯åˆ°ç«¯å¤šç»„å­¦é€šè·¯ä½œç”¨æœºåˆ¶é˜é‡Š**ï¼ˆMulti-Omics Pathway Mechanism Elucidation, MPMEï¼‰æ–¹é¢çš„èƒ½åŠ›ã€‚

åœ¨å¤šç»„å­¦ç ”ç©¶ä¸­ï¼Œç ”ç©¶è€…é€šå¸¸é‡‡ç”¨é€šè·¯å¯Œé›†åˆ†æï¼ˆPathway Enrichment Analysisï¼‰æ¥è§£é‡Šå¤æ‚çš„åˆ†å­å˜åŒ–ã€‚å¦‚ä¸‹å›¾æ‰€ç¤ºï¼š

<div align="center">
  <img src="imgs/pathway_analysis_pipeline.svg" width="48% biological-atom" />
</div>



ç„¶è€Œï¼Œè¿™ç§ä¼ ç»Ÿçš„å¯Œé›†åˆ†ææ³•é¢ä¸´ç€å‡ ä¸ªå…³é”®çš„ç“¶é¢ˆï¼š

1. **ç»´æŠ¤æ»åæ€§ (Curation Lag)**ï¼šé€šè·¯çŸ¥è¯†åº“çš„æ›´æ–°å¾€å¾€æ»åäºæœ€æ–°çš„å­¦æœ¯å‘ç°ã€‚
2. **åŠŸèƒ½å†—ä½™ (Functional Redundancy)**ï¼šå¯Œé›†ç»“æœå¾€å¾€åŒ…å«å¤§é‡é‡å çš„åŸºå› é›†ï¼Œäº§ç”Ÿå†—ä½™çš„é€šè·¯åˆ—è¡¨ï¼Œéš¾ä»¥ç¡®å®šä¼˜å…ˆçº§ã€‚
3. **ä¸Šä¸‹æ–‡ä¸æ•æ„Ÿ (Context-insensitivity)**ï¼šå¯Œé›†åˆ†å€¼å¿½ç•¥äº†åˆ†å­çš„å…·ä½“çŠ¶æ€ï¼ˆå¦‚ç£·é…¸åŒ–ï¼‰ã€å¹²é¢„çš„æ–¹å‘æ€§ä»¥åŠè¿æ¥æ‰°åŠ¨å®ä½“ä¸è¡¨å‹æ‰€éœ€çš„é€»è¾‘å› æœç»“æ„ã€‚

å½“å‰ç ”ç©¶æ–¹æ³•å°è¯•åˆ©ç”¨å¤§è¯­è¨€æ¨¡å‹è§£å†³ä¸Šè¿°é—®é¢˜ï¼Œä½†ç›®å‰**ç¼ºä¹ä¸€ä¸ªèƒ½å¤Ÿè¯„ä¼°æ¨¡å‹â€œç«¯åˆ°ç«¯â€æœºåˆ¶é˜é‡Šèƒ½åŠ›çš„æ ‡å‡†åŒ–åŸºå‡†**â€”â€”å³æ¨¡å‹èƒ½å¦ç›´æ¥ä»â€œæ‰°åŠ¨è§‚æµ‹â€æ¨å¯¼å‡ºè¿è´¯çš„â€œå› æœæœºåˆ¶é“¾æ¡â€ã€‚

**BIOME-Bench** å¡«è¡¥äº†è¿™ä¸€ç©ºç™½ã€‚å®ƒè¦æ±‚æ¨¡å‹åœ¨ç»™å®š**æ‰°åŠ¨å®ä½“**å’Œ**é€šè·¯èƒŒæ™¯**çš„æƒ…å†µä¸‹ï¼Œç›´æ¥ç”Ÿæˆè¿è´¯çš„ã€çŠ¶æ€æ„ŸçŸ¥çš„æœºåˆ¶å‡è¯´ã€‚

ä¸‹å›¾å±•ç¤ºäº†æˆ‘ä»¬ä»æ–‡çŒ®ä¸­æ„å»ºè¿™ä¸€åŸºå‡†æµ‹è¯•çš„æ ¸å¿ƒå·¥ä½œæµï¼š

<div align="center">
  <img src="imgs/workflow.svg" width="80% biological-atom" />
</div>



## ğŸ—ï¸ æ•°æ®æ„å»ºæ–¹æ³•

BIOME-Bench çš„æ•°æ®æ„å»ºå·¥ä½œæµå°†é€šè·¯ä¿¡æ¯ä¸æ–‡çŒ®è¯æ®è½¬åŒ–ä¸ºç»“æ„åŒ–ã€ç»éªŒè¯çš„çŸ¥è¯†è¡¨ç¤ºï¼ŒåŒ…å«ä»¥ä¸‹å››ä¸ªå…³é”®é˜¶æ®µï¼š

### é˜¶æ®µ Iï¼šæ–‡çŒ®æ£€ç´¢ä¸ç›¸å…³æ€§è¿‡æ»¤ (Literature Retrieval and Relevance Filtering)

ä¸ºäº†ç¡®ä¿ç”Ÿç‰©å­¦æœ‰æ•ˆæ€§ï¼Œæ„å»ºè¿‡ç¨‹å§‹äºä¸¥è°¨çš„æ–‡çŒ®è·å–ã€‚ä»¤ $\mathcal{P} = \lbrace p_1, p_2, \dots, p_n\rbrace$ è¡¨ç¤ºé¢„å®šä¹‰çš„ KEGG é€šè·¯é›†ã€‚æ¯ä¸ªé€šè·¯ $p_i$ ç”±å…¶åç§° $N_{p_i}$ å’Œå…³è”ç‰©ç§ $S_{p_i}$ å®šä¹‰ã€‚

- **MeSH å¼•å¯¼çš„æ–‡çŒ®æ£€ç´¢**ï¼š ä¸ºæ¯ä¸ªé€šè·¯ $p_i$ï¼Œæˆ‘ä»¬åœ¨ PubMed æ•°æ®åº“ä¸Šä½¿ç”¨åŒ»å­¦ä¸»é¢˜è¯ï¼ˆMeSHï¼‰è¿›è¡Œç»“æ„åŒ–æ£€ç´¢ï¼Œä»¥æé«˜å¬å›ç²¾åº¦å’Œè¯­ä¹‰ä¸€è‡´æ€§ã€‚æœ€ç»ˆçš„ PubMed æŸ¥è¯¢æ„é€ ä¸ºé€šè·¯ç›¸å…³ MeSH æœ¯è¯­ä¸ç‰©ç§é™åˆ¶çš„äº¤é›†ï¼š

$$
Q(p_i) = \mathrm{MeSH}(N_{p_i}) \wedge \mathrm{MeSH}(S_{p_i}).
$$

  æ‰§è¡Œ $Q(p_i)$ å¾—åˆ°åˆå§‹å€™é€‰æ–‡æ¡£é›† $D_{\text{candidate}}(p_i) = \lbrace d_1, d_2, \dots, d_m \rbrace$ã€‚

- **åŸºäº LLM çš„è¯­ä¹‰ä¸æœºåˆ¶ç›¸å…³æ€§è¯„åˆ†**ï¼š MeSH å¼•å¯¼çš„æ£€ç´¢è™½ç„¶ä¿è¯äº†é«˜å¬å›ç‡ï¼Œä½† MeSH æ³¨é‡Šæœ¬èº«ä¸èƒ½ç¡®ä¿æ–‡ç« åŒ…å«é€šè·¯ç‰¹å®šçš„æœºåˆ¶è¯æ®ã€‚æˆ‘ä»¬ä½¿ç”¨å‚æ•°ä¸º $\theta$ çš„ LLM è¯„ä¼°å™¨ä¸ºæ–‡æ¡£-é€šè·¯å¯¹ $(d, p_i)$ åˆ†é…ç›¸å…³æ€§åˆ†æ•° $s \in [0, 10]$ï¼š

$$
f_{\theta}(d, p_i)=g_{\theta}(\mathbf{S}),
\qquad
\mathbf{S}=
\begin{bmatrix}
S_{\text{subj}}\\
S_{\text{spec}}\\
S_{\text{mol}}\\
S_{\text{ctx}}
\end{bmatrix}.
$$

  å…¶ä¸­ $\mathbf{S}$ åŒ…å«å››ä¸ªç»´åº¦çš„è¯„åˆ†ï¼š

  - **é€šè·¯ä¸»ä½“èšç„¦åº¦ (**$S_{\text{subj}}$**)**ï¼šè¯„ä¼°æ–‡ç« æ˜¯å¦å°†é€šè·¯çš„ç”Ÿç‰©è¿‡ç¨‹ä½œä¸ºä¸»è¦ç ”ç©¶å¯¹è±¡ã€‚
  - **ç‰©ç§ä¸€è‡´æ€§ (**$S_{\text{spec}}$**)**ï¼šè¯„ä¼°ç ”ç©¶ç‰©ç§æ˜¯å¦åŒ¹é…ï¼Œå¹¶è€ƒè™‘æ¨¡å¼ç”Ÿç‰©çš„å…³è”æ€§ã€‚
  - **åˆ†å­åŒ¹é…åº¦ (**$S_{\text{mol}}$**)**ï¼šæ–‡ç« æ˜¯å¦æåŠé€šè·¯å®šä¹‰çš„å…³é”®åˆ†å­å®ä½“ï¼ˆåŸºå› ã€é…¶ã€ä»£è°¢ç‰©ç­‰ï¼‰ã€‚
  - **ä¸Šä¸‹æ–‡è°ƒæ§æè¿° (**$S_{\text{ctx}}$**)**ï¼šæ–‡ç« æ˜¯å¦æè¿°äº†é€šè·¯è°ƒæ§ï¼ˆå¦‚æ¿€æ´»ã€æŠ‘åˆ¶ï¼‰è€Œéä»…æåŠé€šè·¯å­˜åœ¨ã€‚

  ä»…ä¿ç•™ $s \geq 8$ çš„æ–‡æ¡£è¿›å…¥ç›¸å…³æ–‡æ¡£é›† $D_{\text{relevant}}(p_i)$ã€‚

### é˜¶æ®µ IIï¼šä¿¡æ¯æå–ä¸å®ä½“æ ‡å‡†åŒ– (Information Extraction and Entity Standardization)

- **åŸºäº LLM çš„æœºåˆ¶æå–**ï¼š å¯¹äº $D_{\text{relevant}}(p_i)$ ä¸­çš„æ¯ä¸ªæ–‡æ¡£ $d$ï¼Œåˆ©ç”¨ LLM æå–åŸå§‹å®ä½“ï¼ˆåŒ…æ‹¬åŒ–å­¦å“ã€åŸºå› /è›‹ç™½è´¨å’Œè¡¨å‹ï¼‰é›† $E_{\text{raw}}$ ä»¥åŠè¿è´¯çš„è‡ªç„¶è¯­è¨€æœºåˆ¶æè¿° $M_{\text{text}}$ã€‚

- **å®ä½“å½’ä¸€åŒ–ä¸æœ¬ä½“æ˜ å°„**ï¼š ä¸ºäº†ç¡®ä¿ä¸å¤–éƒ¨èµ„æºçš„äº’æ“ä½œæ€§ï¼Œåˆ©ç”¨è§£æå‡½æ•° $\phi(e)$ å°† $E_{\text{raw}}$ æ˜ å°„è‡³è§„èŒƒæ ‡è¯†ç¬¦ï¼ˆåŒ–å­¦å“æ˜ å°„è‡³ PubChem CIDï¼ŒåŸºå› /è›‹ç™½è´¨æ˜ å°„è‡³ NCBI Gene ID/UniProt IDï¼‰ã€‚ä»…ä¿ç•™æ‰€æœ‰å®ä½“å‡èƒ½æˆåŠŸæ ‡å‡†åŒ–çš„æ–‡æ¡£ï¼š

$$
E_{\text{std}}=\left\lbrace \phi(e)\mid e\in E_{\text{raw}} \wedge \forall e'\in E_{\text{raw}},\ \phi(e')\neq\emptyset \right\rbrace
$$

### é˜¶æ®µ IIIï¼šçŸ¥è¯†ç»“æ„åŒ–ä¸æ ¡éªŒ (Knowledge Structuring and Validation)

æ­¤é˜¶æ®µå°†æå–çš„æœºåˆ¶ä¿¡æ¯è½¬æ¢ä¸ºç»†ç²’åº¦çš„çŸ¥è¯†å›¾è°±è¡¨ç¤ºã€‚

- **æ ¸å¿ƒå››å…ƒç»„æå–**ï¼šä» $M_{\text{text}}$ æå–æ ¸å¿ƒç»“æ„ $T_{\text{core}} = (e_s, r, e_t, c)$ï¼Œå…¶ä¸­ $r$ ä¸ºå—æ§è¯è¡¨ä¸­çš„å…³ç³»ç±»å‹ï¼Œ $c$ ä¸ºå®éªŒæ¡ä»¶ã€‚

- **ç”Ÿç‰©çŠ¶æ€æ ‡æ³¨**ï¼šå¼•å…¥æº/ç›®æ ‡å®ä½“çš„ç”Ÿç‰©çŠ¶æ€ $\sigma_s, \sigma_t$ï¼ˆå¦‚çªå˜ã€è¿‡è¡¨è¾¾ã€ç£·é…¸åŒ–ï¼‰ï¼Œæ„å»º**çŠ¶æ€æ„ŸçŸ¥çš„å…­å…ƒç»„ (State-aware Hexaplet)**ï¼š

$$
T_{\text{final}} = (e_s, \sigma_s, r, e_t, \sigma_t, c).
$$

è¿™ç§è¡¨è¿°ä½¿åŸºå‡†èƒ½å¤ŸåŒºåˆ†ç»†å¾®ä½†å…³é”®çš„æœºåˆ¶å·®å¼‚ï¼ˆå¦‚è›‹ç™½ä¸°åº¦å˜åŒ–ä¸ç¿»è¯‘åä¿®é¥°çš„åŒºåˆ«ï¼‰ã€‚

- **ä¸“å®¶éªŒè¯**ï¼šç”±åˆ†å­ç”Ÿç‰©å­¦ä¸“å®¶å¯¹çŸ¥è¯†å›¾è°±æ¡ç›®è¿›è¡ŒæŠ½æ ·æ ¸éªŒï¼Œç¡®ä¿å…¶å‡†ç¡®æ€§ä¸è¯æ®ä¸€è‡´æ€§ã€‚

### é˜¶æ®µ IVï¼šä»»åŠ¡å…¬å¼åŒ– (Task Formulation)

åŸºäºä¸Šè¿°çŸ¥è¯†è¡¨ç¤ºï¼ŒBIOME-Bench å®šä¹‰äº†ä¸¤ä¸ªä»»åŠ¡ï¼š

- **Task A (BII - ç”Ÿç‰©åˆ†å­äº’ä½œæ¨ç†)**ï¼šé¢„æµ‹ç»™å®šé€šè·¯èƒŒæ™¯ $p_i$ã€æºå®ä½“åŠå…¶çŠ¶æ€ã€ç›®æ ‡å®ä½“åŠå…¶çŠ¶æ€ä»¥åŠå®éªŒæ¡ä»¶ä¸‹çš„ç²¾å‡†äº’ä½œå…³ç³»ï¼š

$$
\hat{r} = \arg\max_{r \in \mathcal{R}} P\bigl(r \mid p_i, e_s, \sigma_s, e_t, \sigma_t, c\bigr).
$$

- **Task B (MPME - å¤šç»„å­¦é€šè·¯ä½œç”¨æœºåˆ¶é˜é‡Š)**ï¼šæ¨¡æ‹ŸçœŸå®çš„ç»„å­¦åˆ†æåœºæ™¯ï¼Œç»™å®šé€šè·¯èƒŒæ™¯ $p_i$ å’Œå·®å¼‚è§‚æµ‹é›† $E_{\text{diff}} \subseteq E_{\text{std}}$ï¼Œè¦æ±‚æ¨¡å‹ç”Ÿæˆèƒ½å¤Ÿè§£é‡Šåˆ†å­é—´å¦‚ä½•äº’ç›¸ä½œç”¨å¹¶å¯¼è‡´è¡¨å‹åæœçš„æœºåˆ¶æè¿° $\hat{Y}$ã€‚

## ğŸ“ˆ Benchmarkç»Ÿè®¡

| **Species** | **Pathways** | **Entities** | **Processes & Phenotypes** | **Task A: Biomolecular Interaction Inference** | **Task B: Multi-Omics Pathway Mechanism Elucidation** |
| ----------- | ------------ | ------------ | -------------------------- | ---------------------------------------------- | ----------------------------------------------------- |
| `hsa`       | 80           | 1,349        | 1,781                      | 4,032                                          | 490                                                   |
| `mmu`       | 80           | 1,356        | 1,860                      | 4,162                                          | 496                                                   |
| `rno`       | 80           | 1,141        | 1,265                      | 3,384                                          | 361                                                   |
| **Total**   | **240**      | **3,846**    | **4,906**                  | **11,578**                                     | **1,347**                                             |

**BIOME-Bench** æ˜¯ä¸€ä¸ªæ¶µç›–äº†ä¸‰ç§å¸¸ç”¨ç”Ÿç‰©â€”â€”**äºº (`hsa`)**ã€**å°é¼  (`mmu`)** å’Œ **å¤§é¼  (`rno`)** çš„å¤šç‰©ç§è¯„æµ‹åŸºå‡†ã€‚ä¸Šè¡¨æ±‡æ€»äº†å…¶æ ¸å¿ƒç»Ÿè®¡æ•°æ®ï¼ŒåŒ…æ‹¬ç»è¿‡äººå·¥ç­–å±•çš„é€šè·¯æ•°é‡ã€æ ‡å‡†åŒ–å®ä½“ã€è¿‡ç¨‹ä¸è¡¨å‹æœ¯è¯­ã€æœºåˆ¶åˆ†æå®ä¾‹ä»¥åŠçŸ¥è¯†å›¾è°±å…³ç³»ã€‚æ€»ä½“è€Œè¨€ï¼Œè¯¥åŸºå‡†åŒ…å« **1,347** ä¸ªç”¨äºå¤šç»„å­¦é€šè·¯ä½œç”¨æœºåˆ¶é˜é‡Šçš„å®ä¾‹ï¼Œä»¥åŠ **11,578** ä¸ªç”¨äºç”Ÿç‰©åˆ†å­ç›¸äº’ä½œç”¨æ¨æ–­çš„å®ä¾‹ï¼Œä¸¤è€…å‡åœ¨ä¸€è‡´çš„é€šè·¯èƒŒæ™¯ä¸‹è¿›è¡Œè¯„ä¼°ã€‚

## ğŸ§© è¯„ä¼°åè®®ä¸æŒ‡æ ‡

### Task A: ç”Ÿç‰©åˆ†å­äº’ä½œæ¨ç†

é‡‡ç”¨å…³ç³»æ ‡ç­¾çš„ **Accuracy** å’Œ **Macro-F1** è¿›è¡Œè¯„ä¼°ã€‚

### Task B: å¤šç»„å­¦é€šè·¯æœºåˆ¶é˜é‡Š

é’ˆå¯¹ç”Ÿæˆçš„è§£é‡Šï¼Œæˆ‘ä»¬é‡‡ç”¨å¤šç»´åº¦è¯„ä¼°ç­–ç•¥ï¼š

1. **LLM-as-a-Judge**: ä½¿ç”¨ **Qwen3-32B** ä½œä¸ºè£åˆ¤æ¨¡å‹ï¼Œæ ¹æ® Ground Truth $M_{\text{text}}$ å¯¹ç”Ÿæˆçš„è§£é‡Š $\hat{Y}$ åœ¨å››ä¸ªç»´åº¦ä¸Šè¿›è¡Œè¯„åˆ†ï¼ˆ1-5 åˆ†ï¼‰ï¼š**è¡¨å‹è¦†ç›–åº¦ (Phenotype Coverage)**ã€**å› æœæ¨ç† (Causal Reasoning)**ã€**äº‹å®æ€§ (Factuality)** ä»¥åŠ **å¹»è§‰æ§åˆ¶ (Hallucination Control)**ã€‚

2. **ç»“æ„åŒ–çŸ¥è¯†è¯„ä¼° (Structured Knowledge Evaluation)**: åŸºäºæ–‡çŒ®æ´¾ç”Ÿçš„çŸ¥è¯†å›¾è°±ï¼Œé‡‡ç”¨é—­é›†è¯„ä¼°åè®®ã€‚ä½¿ç”¨ **Qwen3-32B** ä½œä¸ºæå–æ¨¡å‹ï¼Œä»…å…è®¸ä»æ ‡å‡†åŒ–çŸ¥è¯†å›¾ä¸­é€‰æ‹©å…ƒç»„æ¥æ”¯æ’‘è§£é‡Š $\hat{Y}$ ã€‚äº‹å®å®Œæ•´æ€§é€šè¿‡ **Coverage** è¡¡é‡ï¼š

$$
\text{Coverage} = \frac{|\mathcal{T}_{\text{pred}}|}{|\mathcal{T}_{\text{GT}}|}, \mathcal{T}_{\text{pred}}\subseteq\mathcal{T}_{\text{GT}}
$$

3. **è¯­ä¹‰åµŒå…¥ç›¸ä¼¼åº¦ (Semantic Embedding Similarity)**: è®¡ç®—ç”Ÿæˆè§£é‡Š $\hat{Y}$ ä¸æ ‡å‡†æœºåˆ¶æ–‡æœ¬ $M_{\text{text}}$ å‘é‡è¡¨ç¤ºä¹‹é—´çš„ä½™å¼¦ç›¸ä¼¼åº¦ã€‚

## ğŸ“Š å®éªŒç»“æœ

ä¸‹è¡¨å±•ç¤ºäº†ä¸åŒæ¨¡å‹åœ¨ BIOME-Bench ä¸Šçš„æ€§èƒ½è¡¨ç°ï¼š

<div align="center">
  <table style="border-collapse: collapse; width: 100%; font-family: sans-serif; font-size: 13px; text-align: center;">
    <thead>
      <tr style="border-top: 2px solid black;">
        <th rowspan="4" style="border-bottom: 1px solid black; padding: 8px;"><strong>Model</strong></th>
        <th colspan="2" style="padding: 8px;"><strong>Biomolecular Interaction</strong></th>
        <th colspan="6" rowspan="2" style="padding: 8px;"><strong>Multi-Omics Pathway Mechanism Elucidation</strong></th>
        <th rowspan="4" style="border-bottom: 1px solid black; padding: 8px;"><strong>Avg.</strong></th>
      </tr>
      <tr>
        <th colspan="2" style="border-bottom: 1px solid black; padding: 8px;"><strong>Inference</strong></th>
      </tr>
      <tr>
        <th rowspan="2" style="border-bottom: 1px solid black; padding: 8px;">Acc</th>
        <th rowspan="2" style="border-bottom: 1px solid black; padding: 8px;">Macro-F1</th>
        <th colspan="4" style="border-bottom: 1px solid black; padding: 8px;">LLM-as-a-Judge</th>
        <th rowspan="2" style="border-bottom: 1px solid black; padding: 8px;">Similarity</th>
        <th rowspan="2" style="border-bottom: 1px solid black; padding: 8px;">Coverage</th>
      </tr>
      <tr>
        <th style="border-bottom: 1px solid black; padding: 8px;">Phenotype Coverage</th>
        <th style="border-bottom: 1px solid black; padding: 8px;">Causal Reasoning</th>
        <th style="border-bottom: 1px solid black; padding: 8px;">Factuality</th>
        <th style="border-bottom: 1px solid black; padding: 8px;">Hallucination</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left; padding: 6px;">Qwen3-14B</td>
        <td>47.43</td><td>43.72</td><td>3.12</td><td>3.31</td><td>3.97</td><td>4.64</td><td>78.73</td><td>42.38</td><td>64.13</td>
      </tr>
      <tr>
        <td style="text-align: left; padding: 6px;">Qwen3-32B</td>
        <td>41.84</td><td>40.51</td><td>3.00</td><td>3.26</td><td>3.89</td><td>4.79</td><td>78.98</td><td>45.43</td><td>63.20</td>
      </tr>
      <tr>
        <td style="text-align: left; padding: 6px;">Qwen3-235B</td>
        <td>51.41</td><td>46.21</td><td>3.66</td><td>4.32</td><td>4.54</td><td>4.40</td><td>77.34</td><td>42.22</td><td>69.45</td>
      </tr>
      <tr>
        <td style="text-align: left; padding: 6px;">GLM-4.6</td>
        <td>53.60</td><td>50.08</td><td>3.50</td><td>4.14</td><td>4.32</td><td>4.18</td><td>76.89</td><td>39.95</td><td>67.92</td>
      </tr>
      <tr>
        <td style="text-align: left; padding: 6px;">DeepSeek-V3.2-R1</td>
        <td>53.10</td><td>47.52</td><td>3.28</td><td>4.31</td><td>4.20</td><td>4.10</td><td>75.12</td><td>40.76</td><td>66.79</td>
      </tr>
      <tr>
        <td style="text-align: left; padding: 6px;">Gemini3-Pro</td>
        <td>52.34</td><td>46.54</td><td>3.60</td><td>4.57</td><td>4.59</td><td>4.54</td><td>77.21</td><td>41.13</td><td>69.74</td>
      </tr>
      <tr>
        <td style="text-align: left; padding: 6px;">GPT-5.2</td>
        <td>54.66</td><td>50.70</td><td>3.68</td><td>4.58</td><td>4.69</td><td>4.62</td><td>71.38</td><td>37.49</td><td>70.70</td>
      </tr>
      <tr>
        <td style="text-align: left; padding: 6px;">Doubao-Seed-1.8</td>
        <td>55.42</td><td>50.40</td><td>3.81</td><td>4.69</td><td>4.69</td><td>4.57</td><td>74.92</td><td>39.72</td><td>71.96</td>
      </tr>
      <tr style="border-bottom: 2px solid black;">
        <td style="text-align: left; padding: 6px;">Intern-S1-235B</td>
        <td>54.15</td><td>50.36</td><td>3.96</td><td>4.28</td><td>4.75</td><td>4.92</td><td>78.71</td><td>44.49</td><td><strong>73.24</strong></td>
      </tr>
    </tbody>
  </table>
</div>

Qwen3-32B è¯„æµ‹æ¨¡å‹ï¼ˆjudgeï¼‰å¯¹è¯­ä¹‰æ‰°åŠ¨çš„æ•æ„Ÿæ€§å¦‚ä¸‹å›¾æ‰€ç¤ºã€‚å›¾ä¸­è®°å½•äº†æ”¹å†™ï¼ˆrewriteï¼‰ä¸æ‰°åŠ¨ï¼ˆperturbï¼‰åçš„å¾—åˆ†ã€‚Drop% è¡¨ç¤ºä»æ”¹å†™åˆ°æ‰°åŠ¨åçš„å¾—åˆ†ç›¸å¯¹ä¸‹é™ç™¾åˆ†æ¯”ï¼š

<div align="center">
  <img src="imgs/llm_as_a_judge.svg" width="48% biological-atom" />
</div>


å›¾ä¸­ç»“æœéªŒè¯äº†LLM-as-a-Judgeçš„æœ‰æ•ˆæ€§ã€‚

ä¸‹å›¾å±•ç¤ºäº†ç”Ÿç‰©åˆ†å­äº’ä½œæ¨æ–­çš„é”™è¯¯æ··æ·†çŸ©é˜µã€‚è¡Œä»£è¡¨æ ‡æ³¨çœŸå€¼ï¼ˆgoldï¼‰å…³ç³»ç±»å‹ï¼Œåˆ—ä»£è¡¨æ¨¡å‹é¢„æµ‹ç±»å‹ã€‚é¢œè‰²æ·±æµ…è¡¨ç¤ºçœŸå€¼è¢«è¯¯åˆ†ç±»ä¸ºé¢„æµ‹ç±»å‹çš„å…·ä½“æ•°é‡ã€‚



<div align="center">
  <img src="imgs/kg_relation_confusion_matrix.svg" width="45% biological-atom" />
</div>


å›¾ä¸­ç»“æœè¡¨æ˜ï¼šæ¨¡å‹å€¾å‘äºå°†ç²¾ç»†çš„ç”Ÿç‰©æœºåˆ¶è¯¯åˆ¤ä¸ºç²—ç²’åº¦çš„å› æœæˆ–è°ƒèŠ‚å…³ç³»ï¼ˆå¦‚ `leads_to`ï¼‰ï¼Œä¸”éš¾ä»¥å‡†ç¡®åŒºåˆ†ç›´æ¥è°ƒèŠ‚ä¸é€šè·¯å±‚é¢çš„å› æœè”ç³»ã€‚è¿™ç§å¯¹æ¨¡ç³Šå…³ç³»çš„è¿‡åº¦è§£è¯»ï¼ˆå¦‚å°† `regulates` æåŒ–ï¼‰ä»¥åŠç»†ç²’åº¦è¾¨æèƒ½åŠ›çš„ç¼ºå¤±ï¼Œåæ˜ äº†å½“å‰æ¨¡å‹åœ¨å¤„ç†å¤æ‚ç”Ÿç‰©é€»è¾‘æ—¶çš„å±€é™æ€§ã€‚

## ğŸš€ å¿«é€Ÿä¸Šæ‰‹

### 1. ç¯å¢ƒå‡†å¤‡

ç¡®ä¿å·²å®‰è£… Python 3.10+ã€‚

```bash
# å…‹éš†ä»“åº“
git clone url
cd BIOME-Bench

# å®‰è£…ä¾èµ–
pip install -r requirements.txt
```

### 2. é…ç½® (`config/config.json`)

åœ¨è¿è¡Œä¹‹å‰ï¼Œæ‚¨**å¿…é¡»**é…ç½®æ¨¡å‹ç»ˆç«¯ã€‚ä»¥ä¸‹æ˜¯å®Œæ•´çš„é…ç½®æ ·ä¾‹ï¼ŒåŒ…å«å¾…è¯„ä¼°æ¨¡å‹ã€è£åˆ¤æ¨¡å‹å’Œ Embedding æ¨¡å‹çš„è®¾ç½®ï¼š

```json
{
  "EvalModel": {
    "api_config": {
      "model": "EvalModel",
      "base_url": "http://localhost:8000/v1",
      "api_key": "EMPTY",
      "timeout": 60,
      "max_retries": 10
    },
    "generation_config": {
      "temperature": 0.0,
      "max_tokens": 10240,
      "no_think": false,
      "thinking_rules_file": "config/thinking_rules.json"
    },
    "save_every": 10
  },
  "JudgeModel": {
    "api_config": {
      "model": "Qwen3-32B",
      "base_url": "http://localhost:8001/v1",
      "api_key": "sk-..."
    },
    "generation_config": {
      "max_tokens": 10240,
      "temperature": 0.0
    }
  },
  "EmbedModel": {
    "api_config": {
      "model": "Qwen3-8B-Embedding",
      "base_url": "http://localhost:8002/v1",
      "api_key": "sk-..."
    }
  }
}
```

### 3. ä¸€é”®è¿è¡Œ Demo

ä½¿ç”¨ `data/` ä¸­æä¾›çš„ç¤ºä¾‹æ•°æ®å¿«é€ŸéªŒè¯æµç¨‹ï¼š

```bash
# è¿è¡Œ Demoï¼ˆä½¿ç”¨åªæœ‰ä¸€æ¡æ•°æ®çš„æµ‹è¯•é›†è¿›è¡Œå¿«é€ŸéªŒè¯ï¼‰
python run_demo.py --threads 1
```

### 4. ä¸€é”®è¿è¡Œå®Œæ•´æµ‹è¯„

```bash
# è¿è¡Œå®Œæ•´æµ‹è¯„ï¼ˆä½¿ç”¨å®Œæ•´æ•°æ®é›†å’ŒæŒ‡å®šé…ç½®ï¼‰
python run_pipeline.py --config config/my_config.json --threads 1
```

## ğŸ› ï¸ æ‰‹åŠ¨ä½¿ç”¨æµç¨‹

### é˜¶æ®µ 1: æ¨¡å‹æ¨ç†

ä½¿ç”¨ `evaluation` æ¨¡å—å¯¹æ•°æ®é›†è¿›è¡Œæ‰¹å¤„ç†æ¨ç†ã€‚

```bash
# Task-A
python -m evaluation run \
  --data data/TASK-A.jsonl \
  --task-type relation_prediction \
  --config config/config.json \
  --threads 1

# Task-B
python -m evaluation run \
  --data data/TASK-B.jsonl \
  --task-type mechanism_analysis \
  --config config/config.json \
  --threads 1
```

å¦‚æœä½ çš„æ¥å£æ”¯æŒé«˜å¹¶å‘æ¨ç†ï¼Œå¯ä»¥å°†`threads`è°ƒé«˜ä»¥åŠ å¿«è¯„æµ‹ã€‚

### é˜¶æ®µ 2: è¯„åˆ†ä¸æŒ‡æ ‡è®¡ç®—

#### 1. Task A: å…³ç³»é¢„æµ‹å‡†ç¡®ç‡

```bash
python metrics/biomolecular_interaction_inference_acc.py \
  --input outputs/your_run/results.jsonl
```

#### 2. Task B: æœºåˆ¶åˆ†æ (LLM-as-a-Judge)

**æ³¨æ„**ï¼šå¿…é¡»æä¾›ä¸ç‰©ç§å¯¹åº”çš„çŸ¥è¯†åº“æ–‡ä»¶ (`--db`)ã€‚

```bash
python metrics/LLM-as-a-Judge.py \
  --results outputs/your_run/results.jsonl \
  --db data/hsa.jsonl data/mmu.jsonl data/rno.jsonl \
  --output outputs/your_run/judge_results.jsonl \
  --threads 1
```

## ğŸ§  è¿›é˜¶åŠŸèƒ½

### Thinking Rules (`config/thinking_rules.json`)

é’ˆå¯¹ Reasoning æ¨¡å‹ï¼ˆå¦‚ Qwen3ï¼‰çš„ç‰¹æ®Šå¤„ç†é€»è¾‘ï¼Œæ”¯æŒåŠ¨æ€æ³¨å…¥ Prompt å‰ç¼€ã€‚

### æ–­ç‚¹æ¢å¤ä¸é‡è¯• (Resume & Recovery)

æ¡†æ¶ä¼šè‡ªåŠ¨åœ¨è¿è¡Œç›®å½•åˆ›å»º `checkpoint.json`ã€‚è‹¥ä»»åŠ¡ä¸­æ–­ï¼Œé‡æ–°æ‰§è¡Œç›¸åŒå‘½ä»¤æˆ–é€šè¿‡ `--resume-run-id` å³å¯æ¢å¤è¿›åº¦ã€‚

## ğŸ“‚ é¡¹ç›®ç»“æ„

```
BIOME-Bench/
â”œâ”€â”€ config/              # é…ç½®æ–‡ä»¶ä¸æ¨ç†è§„åˆ™
â”œâ”€â”€ data/                # ç»è¿‡æ¸…æ´—çš„çŸ¥è¯†åº“ä¸æµ‹è¯•é›†
â”œâ”€â”€ evaluation/          # æ ¸å¿ƒæ¨ç†å¼•æ“
â”œâ”€â”€ metrics/             # è¯„åˆ†æ¨¡å—ä¸è£åˆ¤ Prompt
â””â”€â”€ outputs/             # å®éªŒç»“æœä¸è¯„ä¼°æŠ¥å‘Š
```

## ğŸ“„ æ•°æ®è¯´æ˜

ä»¥ä¸‹æ˜¯`data\TASK-B.jsonl`ä¸­çš„ä¸€æ¡å¤šç»„å­¦é€šè·¯ä½œç”¨æœºåˆ¶é˜é‡Šæ•°æ®ï¼š

```json
{
    "messages": [
        {
            "role": "user",
            "content": "**Pathway Context**: Bladder cancer - Homo sapiens (human)\n\nDetermine the specific biological relationship between the Source and Target entities under the given Condition.\nYou must select the relationship strictly from the following vocabulary:\n['activates', 'inhibits', 'upregulates_expression', 'downregulates_expression', 'regulates', 'binds', 'dissociates_from', 'phosphorylates', 'dephosphorylates', 'ubiquitinates', 'glycosylates', 'methylates', 'produces', 'consumes', 'converts_to', 'leads_to', 'increases_level', 'decreases_level']\n\n**Source**: SIGLEC12 (elevated expression)\n**Target**: oncogenic signaling (upregulation)\n**Condition**: in bladder cancer\n\nRespond with the exact relation name from the list above."
        },
        {
            "role": "assistant",
            "content": "upregulates_expression"
        }
    ],
    "pathway_id": "hsa05219",
    "pubmed_id": "41303731",
    "species": "hsa"
}
```

å…¶å¯¹åº”çš„è¯¦ç»†é€šè·¯ä¿¡æ¯ã€æ–‡çŒ®ä¿¡æ¯ã€æ–‡çŒ®ç›¸å…³æ€§è¯„ä¼°ç»“æœã€æ ‡å‡†åŒ–çš„å®ä½“å’ŒçŸ¥è¯†å›¾è°±å¯ä»¥åœ¨å¯¹åº”ç‰©ç§çš„`data\hsa.jsonl`ä¸­æ ¹æ®`pathway_id`å’Œ`pubmed_id`æ‰¾åˆ°ï¼š

```json
{
    "id": "hsa05219",
    "name": "Bladder cancer - Homo sapiens (human)",
    "description": "The urothelium covers the luminal surface of almost the entire urinary tract, extending from the renal pelvis, through the ureter and bladder, to the proximal urethra. The majority of urothelial carcinoma are bladder carcinomas, and urothelial carcinomas of the renal pelvis and ureter account for only approximately 7% of the total. Urothelial tumours arise and evolve through divergent phenotypic pathways. Some tumours progress from urothelial hyperplasia to low-grade non-invasive superficial papillary tumours. More aggressive variants arise either from flat, high-grade carcinoma in situ (CIS) and progress to invasive tumours, or they arise de novo as invasive tumours. Low-grade papillary tumors frequently show a constitutive activation of the receptor tyrosine kinase-Ras pathway, exhibiting activating mutations in the HRAS and fibroblast growth factor receptor 3 (FGFR3) genes. In contrast, CIS and invasive tumors frequently show alterations in the TP53 and RB genes and pathways. Invasion and metastases are promoted by several factors that alter the tumour microenvironment, including the aberrant expression of E-cadherins (E-cad), matrix metalloproteinases (MMPs), angiogenic factors such as vascular endothelial growth factor (VEGF).",
    "genes": [
        "1019"
    ],
    "pubmed": [
        {
            "pmid": "41303731",
            "title": "Decoding SIGLEC12 in Bladder Cancer: In Silico Profiling of Expression, Tumor-Immune Interactions, and Prognostic Impact.",
            "abstract": "Background and Objectives: Siglec-XII, encoded by SIGLEC12, is a unique sialic acid-binding immunoglobulin-like lectin. It lacks a highly conserved R122 residue for sialic acid recognition in humans. Although it is upregulated in bladder cancer (BCa), its role in tumorigenesis remains largely unexplored. This study aims to investigate the expression patterns of SIGLEC12 in BCa and its correlation with disease features. Materials and Methods: An integrated analysis of transcriptomic data and clinical profiles was conducted using various databases and tools, including UALCAN, GEPIA, TIMER, CAMOIP, and CPADs. The analyses encompassed SIGLEC12 expression, survival rates, immune infiltration levels, promoter methylation, and correlation with drug response. Results: SIGLEC12 expression was higher in both low-grade papillary and high-grade invasive non-papillary BCa. Higher SIGLEC12 expression resulting from low promoter hypomethylation was detected at the stage II-IV of BCa, and was unrelated to disease stages and metastatic stages. Elevated SIGLEC12 expression correlated with increased immune cell infiltration, higher expression of oncogenic and immune checkpoint blockade-related genes, and drug resistance signatures. Mutation analysis confirmed the absence of the canonical R122 missense mutation, indicating that the structural integrity and potential functionality of Siglec-XII are preserved in BCa. Conclusions: SIGLEC12 may have sialic acid recognition functions and serve as a potential early biomarker of BCa.",
            "authors": "Rathore V; Lin WW",
            "fulltext_url": null,
            "keywords": "Bladder cancer[MeSH Terms] AND human[MeSH Terms]",
            "llm_relevance_assessment": {
                "relevance_score": 8,
                "relevance_level": "High",
                "species_check": "The pathway is human (Homo sapiens), and the article uses human-derived bladder cancer transcriptomic data and clinical profiles. Species match is valid.",    
                "evidence_summary": [
                    "SIGLEC12 expression was higher in both low-grade papillary and high-grade invasive non-papillary BCa.",
                    "Elevated SIGLEC12 expression correlated with increased immune cell infiltration, higher expression of oncogenic and immune checkpoint blockade-related genes, and drug resistance signatures."
                ],
                "reasoning": "The article directly investigates SIGLEC12 in the context of human bladder cancer, aligning with the KEGG pathway 'Bladder cancer - Homo sapiens'. It provides evidence of its expression patterns, association with immune infiltration, and potential role in oncogenic and immune checkpoint-related pathways. While it does not explicitly discuss all the genetic alterations (e.g., FGFR3, TP53, RB) mentioned in the pathway, it offers meaningful biological context and pathway-level insights into tumor-immune interactions and disease progression, placing it in the high relevance category."
            },
            "standardized_entities": {
                "chemicals": [],
                "genes_proteins": [
                    {
                        "original": "SIGLEC12",
                        "standard_name": "SIGLEC12",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "89858",
                        "official_symbol": "SIGLEC12",
                        "full_name": "sialic acid binding Ig like lectin 12",
                        "summary": "Sialic acid-binding immunoglobulin-like lectins (SIGLECs) are a family of cell surface proteins belonging to the immunoglobulin superfamily. They mediate protein-carbohydrate interactions by selectively binding to different sialic acid moieties present on glycolipids and glycoproteins. This gene encodes a member of the SIGLEC3-like subfamily of SIGLECs. Members of this subfamily are characterized by an extracellular V-set immunoglobulin-like domain followed by two C2-set immunoglobulin-like domains, and the cytoplasmic tyrosine-based motifs ITIM and SLAM-like. The encoded protein, upon tyrosine phosphorylation, has been shown to recruit the Src homology 2 domain-containing protein-tyrosine phosphatases SHP1 and SHP2. It has been suggested that the protein is involved in the negative regulation of macrophage signaling by functioning as an inhibitory receptor. This gene is located in a cluster with other SIGLEC3-like genes on 19q13.4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].",
                        "go_process": [
                            "cell adhesion",
                            "cell adhesion"
                        ],
                        "uniprot_id": "Q96PQ1"
                    },
                    {
                        "original": "Siglec-XII",
                        "standard_name": "SIGLEC12",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "89858",
                        "official_symbol": "SIGLEC12",
                        "full_name": "sialic acid binding Ig like lectin 12",
                        "summary": "Sialic acid-binding immunoglobulin-like lectins (SIGLECs) are a family of cell surface proteins belonging to the immunoglobulin superfamily. They mediate protein-carbohydrate interactions by selectively binding to different sialic acid moieties present on glycolipids and glycoproteins. This gene encodes a member of the SIGLEC3-like subfamily of SIGLECs. Members of this subfamily are characterized by an extracellular V-set immunoglobulin-like domain followed by two C2-set immunoglobulin-like domains, and the cytoplasmic tyrosine-based motifs ITIM and SLAM-like. The encoded protein, upon tyrosine phosphorylation, has been shown to recruit the Src homology 2 domain-containing protein-tyrosine phosphatases SHP1 and SHP2. It has been suggested that the protein is involved in the negative regulation of macrophage signaling by functioning as an inhibitory receptor. This gene is located in a cluster with other SIGLEC3-like genes on 19q13.4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].",
                        "go_process": [
                            "cell adhesion",
                            "cell adhesion"
                        ],
                        "uniprot_id": "Q96PQ1"
                    },
                    {
                        "original": "R122",
                        "standard_name": "arginine at position 122 of SIGLEC12",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "89858",
                        "official_symbol": "SIGLEC12",
                        "full_name": "sialic acid binding Ig like lectin 12",
                        "summary": "Sialic acid-binding immunoglobulin-like lectins (SIGLECs) are a family of cell surface proteins belonging to the immunoglobulin superfamily. They mediate protein-carbohydrate interactions by selectively binding to different sialic acid moieties present on glycolipids and glycoproteins. This gene encodes a member of the SIGLEC3-like subfamily of SIGLECs. Members of this subfamily are characterized by an extracellular V-set immunoglobulin-like domain followed by two C2-set immunoglobulin-like domains, and the cytoplasmic tyrosine-based motifs ITIM and SLAM-like. The encoded protein, upon tyrosine phosphorylation, has been shown to recruit the Src homology 2 domain-containing protein-tyrosine phosphatases SHP1 and SHP2. It has been suggested that the protein is involved in the negative regulation of macrophage signaling by functioning as an inhibitory receptor. This gene is located in a cluster with other SIGLEC3-like genes on 19q13.4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].",
                        "go_process": [
                            "cell adhesion",
                            "cell adhesion"
                        ],
                        "uniprot_id": "Q96PQ1"
                    },
                    {
                        "original": "E-cad",
                        "standard_name": "E-cadherin",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "999",
                        "official_symbol": "CDH1",
                        "full_name": "cadherin 1",
                        "summary": "This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015].",
                        "go_process": [
                            "cell morphogenesis",
                            "desmosome assembly",
                            "cell-cell junction assembly"
                        ],
                        "uniprot_id": "P12830"
                    },
                    {
                        "original": "MMPs",
                        "standard_name": "matrix metalloproteinases",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "4319",
                        "official_symbol": "MMP10",
                        "full_name": "matrix metallopeptidase 10",
                        "summary": "This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down fibronectin, laminin, elastin, proteoglycan core protein, gelatins, and several types of collagen. The gene is part of a cluster of MMP genes on chromosome 11. [provided by RefSeq, Jan 2016].",
                        "go_process": [
                            "proteolysis",
                            "proteolysis",
                            "extracellular matrix disassembly"
                        ],
                        "uniprot_id": "P09238"
                    },
                    {
                        "original": "VEGF",
                        "standard_name": "vascular endothelial growth factor",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "2277",
                        "official_symbol": "VEGFD",
                        "full_name": "vascular endothelial growth factor D",
                        "summary": "The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus. [provided by RefSeq, Feb 2011].",
                        "go_process": [
                            "angiogenesis",
                            "response to hypoxia",
                            "sprouting angiogenesis"
                        ],
                        "uniprot_id": "O43915"
                    },
                    {
                        "original": "HRAS",
                        "standard_name": "HRAS",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "3265",
                        "official_symbol": "HRAS",
                        "full_name": "HRas proto-oncogene, GTPase",
                        "summary": "This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008].",
                        "go_process": [
                            "MAPK cascade",
                            "MAPK cascade",
                            "regulation of transcription by RNA polymerase II"
                        ],
                        "uniprot_id": "P01112"
                    },
                    {
                        "original": "FGFR3",
                        "standard_name": "fibroblast growth factor receptor 3",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "2261",
                        "official_symbol": "FGFR3",
                        "full_name": "fibroblast growth factor receptor 3",
                        "summary": "This gene encodes a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and among divergent species. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds acidic and basic fibroblast growth hormone and plays a role in bone development and maintenance. Mutations in this gene lead to craniosynostosis and multiple types of skeletal dysplasia. [provided by RefSeq, Aug 2017].",
                        "go_process": [
                            "MAPK cascade",
                            "skeletal system development",
                            "ossification"
                        ],
                        "uniprot_id": "P22607"
                    },
                    {
                        "original": "TP53",
                        "standard_name": "TP53",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "7157",
                        "official_symbol": "TP53",
                        "full_name": "tumor protein p53",
                        "summary": "This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016].",
                        "go_process": [
                            "negative regulation of transcription by RNA polymerase II",
                            "negative regulation of transcription by RNA polymerase II",
                            "negative regulation of transcription by RNA polymerase II"
                        ],
                        "uniprot_id": "P04637"
                    },
                    {
                        "original": "RB",
                        "standard_name": "RB1",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "5925",
                        "official_symbol": "RB1",
                        "full_name": "RB transcriptional corepressor 1",
                        "summary": "The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008].",
                        "go_process": [
                            "G1/S transition of mitotic cell cycle",
                            "negative regulation of transcription by RNA polymerase II",
                            "negative regulation of transcription by RNA polymerase II"
                        ],
                        "uniprot_id": "P06400"
                    },
                    {
                        "original": "E-cadherins",
                        "standard_name": "E-cadherin",
                        "status": "success",
                        "source_db": "NCBI_Gene",
                        "entrez_id": "999",
                        "official_symbol": "CDH1",
                        "full_name": "cadherin 1",
                        "summary": "This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015].",
                        "go_process": [
                            "cell morphogenesis",
                            "desmosome assembly",
                            "cell-cell junction assembly"
                        ],
                        "uniprot_id": "P12830"
                    }
                ],
                "processes_phenotypes": [
                    {
                        "original": "Bladder cancer",
                        "type": "phenotype"
                    },
                    {
                        "original": "Immune cell infiltration",
                        "type": "phenotype"
                    },
                    {
                        "original": "Oncogenic signaling",
                        "type": "phenotype"
                    },
                    {
                        "original": "Immune checkpoint blockade",
                        "type": "phenotype"
                    },
                    {
                        "original": "Drug resistance",
                        "type": "phenotype"
                    },
                    {
                        "original": "Tumor progression",
                        "type": "phenotype"
                    },
                    {
                        "original": "Metastasis",
                        "type": "phenotype"
                    }
                ]
            },
            "knowledge_graph": [
                {
                    "source": "SIGLEC12",
                    "source_state": "elevated expression",
                    "relation": "upregulates_expression",
                    "target": "oncogenic signaling",
                    "target_state": "upregulation",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "SIGLEC12",
                    "source_state": "elevated expression",
                    "relation": "upregulates_expression",
                    "target": "immune checkpoint blockade",
                    "target_state": "upregulation",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "SIGLEC12",
                    "source_state": "elevated expression",
                    "relation": "increases_level",
                    "target": "immune cell infiltration",
                    "target_state": "increased",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "SIGLEC12",
                    "source_state": "elevated expression",
                    "relation": "leads_to",
                    "target": "drug resistance",
                    "target_state": "drug resistance signatures",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "alterations in TP53",
                    "source_state": "alterations",
                    "relation": "leads_to",
                    "target": "tumor progression",
                    "target_state": "invasive tumor progression",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "alterations in RB1",
                    "source_state": "alterations",
                    "relation": "leads_to",
                    "target": "tumor progression",
                    "target_state": "invasive tumor progression",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "HRAS mutations",
                    "source_state": "mutations",
                    "relation": "leads_to",
                    "target": "low-grade papillary tumors",
                    "target_state": "Present",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "FGFR3 mutations",
                    "source_state": "mutations",
                    "relation": "leads_to",
                    "target": "low-grade papillary tumors",
                    "target_state": "Present",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "E-cadherin loss",
                    "source_state": "loss",
                    "relation": "facilitates",
                    "target": "tumor invasion",
                    "target_state": "Present",
                    "condition": "General"
                },
                {
                    "source": "matrix metalloproteinases",
                    "source_state": "Present",
                    "relation": "facilitates",
                    "target": "tumor invasion",
                    "target_state": "Present",
                    "condition": "General"
                },
                {
                    "source": "vascular endothelial growth factor",
                    "source_state": "Present",
                    "relation": "promotes",
                    "target": "angiogenesis",
                    "target_state": "Present",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "angiogenesis",
                    "source_state": "Present",
                    "relation": "supports",
                    "target": "tumor growth",
                    "target_state": "Present",
                    "condition": "in bladder cancer"
                },
                {
                    "source": "angiogenesis",
                    "source_state": "Present",
                    "relation": "supports",
                    "target": "metastasis",
                    "target_state": "Present",
                    "condition": "in bladder cancer"
                }
            ]
        }
    ]
}
```

## ğŸ™ è‡´è°¢

æ„Ÿè°¢ä»¥ä¸‹é¡¹ç›®å¯¹æœ¬å·¥ä½œçš„æ”¯æŒï¼š

- [KEGG](https://www.kegg.jp/)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [PubChem](https://pubchem.ncbi.nlm.nih.gov/)
- [PubChemPy](https://github.com/mcs07/PubChemPy)
- [Genes - NCBI](https://uud.ncbi.nlm.nih.gov/home/genes/)
- [UniProt](https://www.uniprot.org/)
- [MyGene.info](https://github.com/biothings/mygene.info)
- [Qwen3](https://github.com/QwenLM/Qwen3)
- [GLM-4.6](https://huggingface.co/zai-org/GLM-4.6)
- [DeepSeek-R1](https://github.com/deepseek-ai/DeepSeek-R1)
- [Gemini 3](https://blog.google/products/gemini/gemini-3/)
- [GPT-5.2](https://openai.com/zh-Hans-CN/index/introducing-gpt-5-2/)
- [Doubao-Seed-1.8](https://console.volcengine.com/ark/region:ark+cn-beijing/model/detail?Id=doubao-seed-1-8)
- [Intern-S1](https://github.com/InternLM/Intern-S1)
- [Qwen3-Embedding](https://github.com/QwenLM/Qwen3-Embedding)
- [vllm](https://github.com/vllm-project/vllm)

## ğŸ“ å¼•ç”¨

```
@misc{biomebench2025,
  title = {BIOME-Bench: A Benchmark for Biomolecular Interaction Inference and Multi-Omics Pathway Mechanism Elucidation},
  year = {2025},
  publisher = {GitHub},
  journal = {GitHub repository}
}
```